Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Holly Lindsay

Concepts (224)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms
18
2026
1327
2.820
Why?
Medulloblastoma
7
2024
215
2.070
Why?
Central Nervous System Neoplasms
7
2025
175
1.650
Why?
Cerebellar Neoplasms
6
2024
177
1.600
Why?
Ependymoma
5
2026
176
1.370
Why?
Glioma
9
2025
429
1.310
Why?
Neoplastic Syndromes, Hereditary
2
2019
47
1.170
Why?
Glioblastoma
4
2026
353
1.100
Why?
Oligodendrocyte Transcription Factor 2
1
2026
23
0.940
Why?
Lymphopenia
1
2024
64
0.820
Why?
Neoplasm Recurrence, Local
3
2026
1145
0.810
Why?
Hemophilia A
2
2014
147
0.710
Why?
Poly-ADP-Ribose Binding Proteins
1
2019
35
0.610
Why?
Neurocutaneous Syndromes
1
2019
3
0.610
Why?
DNA Polymerase II
1
2019
35
0.610
Why?
Child
33
2026
22600
0.560
Why?
Cephalosporins
1
2017
47
0.500
Why?
Xenograft Model Antitumor Assays
5
2026
925
0.500
Why?
Factor VIII
2
2014
105
0.500
Why?
Neoplasm Transplantation
2
2020
246
0.490
Why?
Germinoma
1
2016
10
0.480
Why?
Proto-Oncogene Proteins c-kit
1
2016
72
0.460
Why?
Renal Insufficiency
1
2017
172
0.440
Why?
Antineoplastic Agents
6
2025
2201
0.430
Why?
Granuloma, Pyogenic
1
2014
10
0.420
Why?
Coagulants
1
2014
19
0.420
Why?
von Willebrand Disease, Type 2
1
2014
1
0.420
Why?
Infratentorial Neoplasms
2
2026
71
0.420
Why?
Mouth Diseases
1
2014
47
0.410
Why?
Child, Preschool
16
2026
11790
0.400
Why?
DNA Repair Enzymes
1
2013
29
0.380
Why?
Prognosis
10
2026
4312
0.380
Why?
Neoplasms, Multiple Primary
1
2013
58
0.370
Why?
Adenosine Triphosphatases
1
2013
161
0.360
Why?
Neoplasms
5
2026
2873
0.350
Why?
Gene Deletion
1
2013
392
0.340
Why?
Colorectal Neoplasms
1
2019
849
0.340
Why?
Colonic Neoplasms
1
2013
256
0.330
Why?
DNA-Binding Proteins
2
2019
1484
0.320
Why?
Chemoradiotherapy
3
2026
239
0.300
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2026
1961
0.290
Why?
Humans
40
2026
144671
0.290
Why?
Follow-Up Studies
8
2026
5414
0.290
Why?
Adolescent
16
2026
22409
0.280
Why?
Cancer Survivors
2
2026
330
0.270
Why?
Neoplastic Stem Cells
3
2024
407
0.260
Why?
Survival Rate
4
2026
2089
0.250
Why?
Anti-Bacterial Agents
1
2017
1928
0.240
Why?
Male
21
2026
72431
0.240
Why?
Proto-Oncogene Proteins c-mdm2
1
2026
67
0.240
Why?
Cell Line, Tumor
6
2026
3523
0.230
Why?
Adenocarcinoma
1
2013
923
0.230
Why?
Trastuzumab
1
2026
117
0.230
Why?
Hydroxamic Acids
1
2025
94
0.230
Why?
Female
22
2026
78304
0.230
Why?
Pyrimidines
4
2025
519
0.230
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2026
161
0.220
Why?
Mice, SCID
4
2021
368
0.220
Why?
Cisplatin
2
2024
339
0.220
Why?
Receptor, trkA
1
2025
18
0.220
Why?
Gene Fusion
1
2025
30
0.220
Why?
Proton Therapy
1
2024
15
0.210
Why?
AC133 Antigen
1
2024
20
0.210
Why?
CD57 Antigens
1
2024
18
0.210
Why?
Craniospinal Irradiation
1
2024
5
0.210
Why?
Gangliosides
1
2024
23
0.210
Why?
Hematologic Neoplasms
1
2026
163
0.210
Why?
MicroRNAs
2
2021
689
0.200
Why?
Histone Deacetylase Inhibitors
1
2025
218
0.200
Why?
Aftercare
1
2026
222
0.200
Why?
Cochlea
1
2024
73
0.200
Why?
Antimetabolites, Antineoplastic
1
2024
105
0.200
Why?
Young Adult
10
2026
14122
0.200
Why?
Infant
9
2026
10023
0.190
Why?
Methotrexate
1
2024
231
0.190
Why?
Proto-Oncogene Proteins
1
2026
619
0.190
Why?
Oncogene Proteins, Fusion
1
2025
211
0.190
Why?
Biomarkers, Tumor
4
2019
1319
0.190
Why?
Cell Survival
1
2026
1092
0.190
Why?
Neoplasm Invasiveness
1
2024
503
0.180
Why?
Symporters
1
2022
48
0.180
Why?
Cell Cycle Proteins
1
2026
628
0.180
Why?
Aurora Kinase A
2
2023
61
0.180
Why?
Craniopharyngioma
1
2023
77
0.180
Why?
Spinal Cord Neoplasms
1
2022
41
0.180
Why?
Azepines
2
2023
106
0.170
Why?
Rhabdoid Tumor
1
2023
102
0.170
Why?
Enhancer of Zeste Homolog 2 Protein
1
2021
55
0.170
Why?
Nuclear Proteins
1
2026
741
0.170
Why?
Gadolinium
1
2021
84
0.170
Why?
Pituitary Neoplasms
1
2023
190
0.170
Why?
Phenotype
3
2021
3147
0.160
Why?
Hearing Loss
1
2024
249
0.160
Why?
Peptides
1
2026
989
0.160
Why?
Product Surveillance, Postmarketing
1
2020
73
0.160
Why?
Tumor Suppressor Protein p53
2
2026
532
0.160
Why?
Hypothalamic Diseases
1
2020
17
0.160
Why?
Legislation, Drug
1
2020
73
0.160
Why?
Mice
8
2026
18261
0.160
Why?
Methylphenidate
1
2020
49
0.150
Why?
Mutation
5
2026
4081
0.150
Why?
Neurofibromin 1
1
2019
26
0.150
Why?
Survival Analysis
3
2020
1370
0.150
Why?
Protein Kinase Inhibitors
3
2025
971
0.150
Why?
N-Myc Proto-Oncogene Protein
1
2019
11
0.150
Why?
Chromosomes, Human, Pair 19
1
2019
26
0.150
Why?
DNA Mismatch Repair
1
2019
53
0.150
Why?
Germ Cells
1
2019
65
0.150
Why?
Animals
11
2026
37948
0.150
Why?
Histones
2
2022
663
0.140
Why?
Pharmaceutical Preparations
1
2020
170
0.140
Why?
Digoxin
1
2018
27
0.140
Why?
Multigene Family
1
2019
210
0.140
Why?
Germ-Line Mutation
1
2019
176
0.140
Why?
Drug Repositioning
1
2018
40
0.140
Why?
DNA Mutational Analysis
1
2019
409
0.140
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
259
0.140
Why?
Retrospective Studies
7
2025
17149
0.140
Why?
Central Nervous System Stimulants
1
2020
185
0.140
Why?
Enzyme Inhibitors
1
2021
820
0.140
Why?
Neoplasms, Germ Cell and Embryonal
1
2019
76
0.140
Why?
Adult
8
2026
40489
0.140
Why?
Systems Biology
1
2018
72
0.130
Why?
Cell Culture Techniques
1
2020
372
0.130
Why?
Neoplasm Metastasis
2
2021
691
0.130
Why?
Fever of Unknown Origin
1
2017
13
0.130
Why?
Quality Improvement
1
2026
1287
0.120
Why?
Caregivers
1
2026
1062
0.120
Why?
Genetic Testing
1
2019
480
0.120
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2019
293
0.120
Why?
Quality of Life
3
2023
3183
0.120
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2017
89
0.120
Why?
Radiation Tolerance
1
2016
103
0.120
Why?
Proto-Oncogene Proteins c-fos
1
2016
194
0.120
Why?
Heterografts
1
2016
143
0.110
Why?
Immunohistochemistry
2
2018
1705
0.110
Why?
Magnetic Resonance Imaging
3
2023
3888
0.110
Why?
RNA-Binding Proteins
1
2019
461
0.110
Why?
Treatment Outcome
6
2026
11735
0.110
Why?
Weight Loss
1
2020
839
0.100
Why?
Chromosome Aberrations
1
2014
164
0.100
Why?
Genetic Predisposition to Disease
2
2019
2350
0.100
Why?
von Willebrand Factor
1
2014
85
0.100
Why?
Pediatrics
1
2022
1121
0.100
Why?
Mismatch Repair Endonuclease PMS2
1
2013
4
0.100
Why?
Morpholines
2
2025
129
0.100
Why?
Heterozygote
1
2014
313
0.100
Why?
Sequence Analysis, DNA
1
2016
828
0.090
Why?
Combined Modality Therapy
2
2026
1268
0.080
Why?
Neoplasm Grading
2
2024
310
0.080
Why?
Alleles
1
2013
886
0.080
Why?
Risk Factors
1
2024
10796
0.080
Why?
Mice, Inbred NOD
2
2021
610
0.070
Why?
Brain
2
2021
2934
0.070
Why?
Recurrence
2
2022
1136
0.070
Why?
Cell Proliferation
3
2021
2489
0.060
Why?
Tumor Cells, Cultured
2
2020
881
0.060
Why?
Obesity
1
2020
3070
0.060
Why?
Epigenesis, Genetic
2
2022
669
0.060
Why?
Injections, Spinal
1
2026
120
0.060
Why?
Circulating Tumor DNA
1
2026
45
0.060
Why?
Sulfur Compounds
1
2025
7
0.060
Why?
Maximum Tolerated Dose
1
2025
211
0.060
Why?
Apoptosis
3
2018
2397
0.050
Why?
Disease Models, Animal
3
2021
4539
0.050
Why?
Cell Cycle
2
2019
595
0.050
Why?
Receptor, trkB
1
2025
39
0.050
Why?
Interleukin-7 Receptor alpha Subunit
1
2024
11
0.050
Why?
Mucositis
1
2024
20
0.050
Why?
Chromosomes
1
2024
108
0.050
Why?
Neutropenia
1
2024
155
0.050
Why?
Fluorouracil
1
2024
234
0.050
Why?
Infant, Newborn
1
2014
6399
0.050
Why?
Biphenyl Compounds
1
2021
66
0.040
Why?
Dissection
1
2021
56
0.040
Why?
Radiotherapy Dosage
1
2021
288
0.040
Why?
Drug Evaluation, Preclinical
1
2021
195
0.040
Why?
Serial Passage
1
2020
2
0.040
Why?
Pyrazoles
1
2025
512
0.040
Why?
Government Regulation
1
2020
39
0.040
Why?
Benzamides
1
2021
224
0.040
Why?
Drug Interactions
1
2022
401
0.040
Why?
Patient-Specific Modeling
1
2020
45
0.040
Why?
Immunotherapy, Adoptive
1
2024
339
0.040
Why?
Drug Resistance, Neoplasm
1
2025
881
0.040
Why?
United States Food and Drug Administration
1
2020
205
0.040
Why?
Pyridones
1
2021
201
0.040
Why?
Thalamus
1
2021
127
0.040
Why?
Chromosomes, Human, Pair 2
1
2019
28
0.040
Why?
Osteosarcoma
1
2019
76
0.040
Why?
Rhabdomyosarcoma
1
2019
64
0.040
Why?
Medical Oncology
1
2022
331
0.040
Why?
Oncogenes
1
2019
118
0.040
Why?
Wilms Tumor
1
2019
86
0.040
Why?
DNA Copy Number Variations
1
2019
184
0.030
Why?
Sarcoma, Ewing
1
2019
103
0.030
Why?
Radiation, Ionizing
1
2018
86
0.030
Why?
Neuroblastoma
1
2019
174
0.030
Why?
Contrast Media
1
2021
492
0.030
Why?
Enhancer Elements, Genetic
1
2019
192
0.030
Why?
DNA Methylation
1
2022
664
0.030
Why?
Genetic Association Studies
1
2019
369
0.030
Why?
Cell Transformation, Neoplastic
1
2019
337
0.030
Why?
Age Factors
1
2024
3329
0.030
Why?
Immunophenotyping
1
2018
318
0.030
Why?
Gene Regulatory Networks
1
2019
319
0.030
Why?
Blood-Brain Barrier
1
2018
155
0.030
Why?
Cytogenetic Analysis
1
2014
33
0.030
Why?
Serum Albumin, Bovine
1
2014
59
0.030
Why?
Gene Expression Profiling
1
2021
1766
0.030
Why?
Transplantation, Heterologous
1
2014
169
0.030
Why?
Clinical Trials as Topic
1
2019
1056
0.030
Why?
Genomics
1
2019
831
0.030
Why?
Flow Cytometry
1
2018
1154
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2018
1437
0.020
Why?
Cattle
1
2014
975
0.020
Why?
Mitochondria
1
2018
984
0.020
Why?
Models, Biological
1
2019
1811
0.020
Why?
Aged
2
2025
25955
0.020
Why?
Gene Expression Regulation
1
2019
2591
0.020
Why?
Middle Aged
2
2025
35971
0.020
Why?
Biomarkers
1
2018
4261
0.020
Why?
Signal Transduction
1
2018
5185
0.010
Why?
United States
1
2020
16018
0.010
Why?
Lindsay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)